Company Quick10K Filing
Equitable Financial
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-K 2017-06-30 Annual: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-K 2016-06-30 Annual: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-K 2015-06-30 Annual: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
8-K 2018-07-10 Exhibits

Equitable Financial Financials

-

EQFN Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash20,23521,51310,28220,77231,30114,9478,9234,4687,4075,0464,5944,90235,987
Accounts Receivable
Inventory
PP&E10,20110,0035,4775,4135,34010,0635,5175,4895,46010,3355,4375,3855,369
Assets200,726215,030211,647222,973234,454225,087227,873231,182241,259253,842262,801270,277305,668
Accounts Payable
Long-Term Debt
Liabilities179,481193,582176,023187,093198,279188,548191,022194,794204,751217,456226,019233,588269,015
Stockholders' Equity20,80020,93135,11635,37035,58035,97436,27135,72935,82635,57135,94635,81435,659
Income Statement ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax404170115156155141163222139192283465155
Net Income615165275222328-107350
Cash Flow ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash Operating791-1222,372
Cash Investing-9,351-6,427-5,210
Cash Financing8,2736,85833,923